True: increased costs can sometimes be a red flag, but I do believe it's warranted here as they ramp up R&D and international sales/pre-sales.
At this point, I'm happy to give them benefit of the doubt, but will watch the cost creep over the coming quarters.
Add to My Watchlist
What is My Watchlist?